marketcaparena
Search

    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Company overview

    Market capitalization
    —
    Employees
    2,475
    Latest publication
    2026-09-29
    About PHIBRO ANIMAL HEALTH CORP

    Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Revenue396,700,000USD383,543,000USD373,910,000USD363,893,000USD378,697,000USD347,825,000USD309,261,000USD260,432,000USD
    Cost Of Revenue262,300,000USD257,868,000USD241,254,000USD244,110,000USD268,688,000USD243,257,000USD207,391,000USD176,937,000USD
    Gross Profit134,400,000USD124,873,000USD132,656,000USD119,783,000USD110,009,000USD104,568,000USD101,870,000USD83,495,000USD
    Selling General Administrative86,200,000USD81,022,000USD82,330,000USD68,523,000USD76,291,000USD71,053,000USD76,337,000USD65,796,000USD
    Operating Income48,200,000USD47,975,000USD54,414,000USD47,891,000USD33,718,000USD33,515,000USD25,533,000USD17,699,000USD
    Income Before Tax32,300,000USD32,313,000USD36,425,000USD36,267,000USD23,847,000USD29,688,000USD4,838,000USD9,620,000USD
    Income Tax Expense10,600,000USD8,289,000USD8,966,000USD9,740,000USD6,623,000USD8,808,000USD1,653,000USD2,645,000USD
    Net Income21,700,000USD24,024,000USD27,459,000USD26,527,000USD17,224,000USD20,880,000USD3,185,000USD6,975,000USD
    Unclassified Operating Expenses—-4,124,000USD-4,425,000USD2,932,000USD-23,726,000USD———
    Total Operating Expenses—76,898,000USD77,905,000USD71,455,000USD76,291,000USD71,053,000USD76,337,000USD65,796,000USD
    Interest Income—250,000USD725,000USD484,000USD418,000USD298,000USD782,000USD1,124,000USD
    Interest Expense—10,880,000USD13,060,000USD13,481,000USD8,456,000USD13,095,000USD9,164,000USD8,172,000USD
    Net Interest Income—-10,431,000USD-11,756,000USD-12,059,000USD-8,610,000USD-9,355,000USD-8,996,000USD-7,641,000USD
    Tax Provision—8,289,000USD8,966,000USD9,740,000USD6,623,000USD8,808,000USD1,653,000USD2,645,000USD
    Net Income From Continuing Ops—24,024,000USD27,459,000USD26,527,000USD17,224,000USD20,880,000USD3,185,000USD6,975,000USD
    Ebit—47,975,000USD54,414,000USD49,748,000USD32,303,000USD38,769,000USD14,002,000USD17,792,000USD
    Ebitda—60,423,000USD67,305,000USD62,578,000USD44,714,000USD51,385,000USD25,576,000USD26,796,000USD
    Depreciation And Amortization—12,448,000USD12,891,000USD12,830,000USD12,411,000USD12,616,000USD11,574,000USD9,004,000USD
    Reconciled Depreciation—12,448,000USD12,891,000USD12,830,000USD12,411,000USD12,616,000USD11,574,000USD9,004,000USD
    Total Other Income Expense Net—-15,662,000USD-17,989,000USD-11,624,000USD-9,871,000USD-3,827,000USD-20,695,000USD-8,079,000USD
    Research Development————23,726,000USD———
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Revenue1,518,093,000USD1,296,215,000USD1,017,679,000USD977,889,000USD942,261,000USD833,350,000USD800,354,000USD828,000,000USD
    Cost Of Revenue1,005,578,000USD896,273,000USD704,587,000USD679,652,000USD656,861,000USD561,973,000USD543,472,000USD563,400,000USD
    Gross Profit512,515,000USD399,942,000USD313,092,000USD298,237,000USD285,400,000USD271,377,000USD256,882,000USD264,600,000USD
    Research Development24,551,000USD23,726,000USD29,194,000USD24,395,000USD20,832,000USD17,759,000USD13,738,000USD12,083,000USD
    Selling General Administrative318,119,000USD289,477,000USD259,777,000USD226,390,000USD206,414,000USD196,509,000USD187,688,000USD181,398,000USD
    Total Operating Expenses318,119,000USD289,477,000USD259,777,000USD226,390,000USD206,414,000USD196,509,000USD187,688,000USD181,400,000USD
    Operating Income194,396,000USD110,465,000USD53,315,000USD71,847,000USD78,986,000USD74,868,000USD69,194,000USD73,301,000USD
    Total Other Income Expense Net-57,050,000USD-42,472,000USD-42,399,000USD-17,776,000USD-6,659,000USD-8,400,000USD-13,682,000USD-11,721,000USD
    Interest Expense46,416,000USD33,249,000USD21,970,000USD17,949,000USD12,101,000USD10,401,000USD14,303,000USD13,677,000USD
    Income Before Tax137,346,000USD67,993,000USD10,916,000USD54,071,000USD72,327,000USD66,468,000USD55,512,000USD71,500,000USD
    Income Tax Expense37,626,000USD19,729,000USD8,500,000USD21,465,000USD23,152,000USD12,083,000USD21,960,000USD16,800,000USD
    Net Income99,720,000USD48,264,000USD2,416,000USD32,606,000USD49,175,000USD54,385,000USD33,552,000USD54,700,000USD
    Net Income Applicable To Common Shares99,720,000USD——32,606,000USD49,175,000USD54,385,000USD33,552,000USD54,713,000USD
    Unclassified Operating Expenses—-23,726,000USD-29,194,000USD-24,395,000USD-20,832,000USD-17,759,000USD-13,738,000USD-12,081,000USD
    Interest Income—2,622,000USD4,474,000USD3,355,000USD816,000USD838,000USD1,757,000USD1,901,000USD
    Net Interest Income—-34,602,000USD-18,536,000USD-15,321,000USD-11,875,000USD-12,880,000USD-12,856,000USD-11,776,000USD
    Tax Provision—19,729,000USD8,500,000USD21,465,000USD23,152,000USD12,083,000USD21,960,000USD16,792,000USD
    Net Income From Continuing Ops—48,264,000USD2,416,000USD32,606,000USD49,175,000USD54,385,000USD33,552,000USD54,713,000USD
    Ebit—101,242,000USD32,886,000USD72,020,000USD84,428,000USD78,333,000USD69,243,000USD85,182,000USD
    Ebitda—146,847,000USD69,064,000USD106,032,000USD117,133,000USD110,213,000USD101,584,000USD112,746,000USD
    Depreciation And Amortization—45,605,000USD36,178,000USD34,012,000USD32,705,000USD31,880,000USD32,341,000USD27,564,000USD
    Reconciled Depreciation—45,605,000USD36,178,000USD34,012,000USD32,705,000USD31,885,000USD32,341,000USD27,564,000USD
    Non Operating Income Net Other———-2,455,000USD5,216,000USD4,480,000USD-826,000USD55,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Assets1,501,241,000USD1,445,118,000USD1,405,553,000USD1,385,524,000USD1,360,900,000USD1,317,260,000USD1,285,509,000USD966,289,000USD
    Cash And Equivalents61,419,000USD———————
    Cash And Short Term Investments81,994,000USD77,451,000USD74,508,000USD85,273,000USD77,039,000USD70,354,000USD67,074,000USD89,837,000USD
    Short Term Investments20,575,000USD22,522,000USD19,022,000USD12,504,000USD9,000,000USD10,000,000USD0USD38,000,000USD
    Long Term Investments8,759,000USD12,268,000USD12,669,000USD13,358,000USD11,689,000USD11,350,000USD11,883,000USD11,848,000USD
    Total Current Assets935,506,000USD894,068,000USD862,185,000USD835,799,000USD810,606,000USD776,018,000USD746,153,000USD570,767,000USD
    Other Current Assets79,835,000USD55,372,000USD54,458,000USD60,855,000USD61,159,000USD59,756,000USD60,066,000USD47,597,000USD
    Other Non Current Assets106,464,000USD———————
    Total Liabilities1,115,764,000USD———————
    Total Current Liabilities316,468,000USD281,870,000USD282,370,000USD270,139,000USD293,473,000USD266,481,000USD233,250,000USD176,894,000USD
    Other Current Liabilities29,933,000USD———————
    Other Non Current Liabilities91,527,000USD———————
    Total Stockholder Equity385,477,000USD361,827,000USD332,361,000USD311,681,000USD285,682,000USD265,992,000USD246,802,000USD258,527,000USD
    Total Equity Including Noncontrolling Interest385,477,000USD———————
    Net Receivables238,794,000USD221,546,000USD215,872,000USD217,896,000USD227,983,000USD197,518,000USD191,789,000USD160,777,000USD
    Inventory534,883,000USD539,699,000USD517,347,000USD471,775,000USD444,425,000USD448,390,000USD427,224,000USD272,556,000USD
    Property Plant Equipment Net420,748,000USD408,508,000USD355,381,000USD394,926,000USD396,029,000USD378,332,000USD375,021,000USD243,874,000USD
    Goodwill60,045,000USD———————
    Accounts Payable127,314,000USD129,643,000USD133,296,000USD130,597,000USD138,201,000USD131,622,000USD99,445,000USD86,528,000USD
    Short Term Debt10,572,000USD32,250,000USD29,597,000USD27,465,000USD25,377,000USD25,238,000USD24,269,000USD15,397,000USD
    Retained Earnings352,958,000USD336,115,000USD316,959,000USD294,364,000USD272,701,000USD260,341,000USD244,326,000USD246,001,000USD
    Accumulated Other Comprehensive Income-106,077,000USD-112,470,999USD-122,370,000USD-120,021,000USD-124,018,000USD-131,169,000USD-134,165,000USD-123,935,000USD
    Intangible Assets—31,685,000USD33,066,000USD34,964,000USD36,469,000USD37,766,000USD39,894,000USD42,935,000USD
    Total Liab—1,083,291,000USD1,073,192,000USD1,073,843,000USD1,075,218,000USD1,051,268,000USD1,038,707,000USD707,762,000USD
    Other Current Liab—119,977,000USD119,477,000USD112,077,000USD121,498,000USD103,273,000USD105,705,000USD69,426,000USD
    Common Stock—4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Capital Stock—4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Good Will—59,889,000USD59,814,000USD59,708,000USD59,645,000USD54,570,000USD54,549,000USD54,588,000USD
    Cash—54,929,000USD55,486,000USD72,769,000USD68,039,000USD60,354,000USD67,074,000USD51,837,000USD
    Net Debt—732,515,000USD717,681,000USD712,330,000USD693,513,000USD709,667,000USD722,390,000USD460,047,000USD
    Short Long Term Debt—22,831,000USD20,638,000USD18,444,000USD16,250,000USD16,250,000USD16,250,000USD7,500,000USD
    Short Long Term Debt Total—787,444,000USD773,167,000USD785,099,000USD761,552,000USD770,021,000USD789,464,000USD511,884,000USD
    Long Term Debt—712,685,000USD710,602,000USD724,518,000USD702,435,000USD711,157,000USD736,880,000USD466,668,000USD
    Property Plant Equipment Gross—408,508,000USD394,797,000USD394,926,000USD674,989,000USD378,332,000USD375,021,000USD243,874,000USD
    Common Stock Shares Outstanding—41,037,000shares40,956,000shares40,877,000shares40,700,000shares40,709,000shares40,715,000shares40,582,000shares
    Non Current Assets Total—551,050,000USD543,368,000USD549,724,999USD550,294,000USD541,242,000USD539,356,000USD395,522,000USD
    Non Current Liabilities Total—801,420,999USD790,822,000USD803,704,000USD781,745,000USD784,787,000USD805,457,000USD530,868,000USD
    Non Current Liabilities Other—10,514,000USD10,478,000USD10,822,000USD11,361,000USD12,173,000USD11,779,000USD6,493,000USD
    Non Currrent Assets Other—22,445,000USD82,071,000USD23,182,999USD20,914,000USD23,052,000USD24,214,000USD16,751,000USD
    Net Working Capital—612,198,000USD579,815,000USD565,660,000USD517,133,000USD509,537,000USD512,903,000USD393,873,000USD
    Unclassified Non Current Assets—16,255,000USD—23,586,000USD25,548,000USD36,172,000USD33,795,000USD25,526,000USD
    Unclassified Current Liabilities—-22,831,000USD-20,638,000USD-18,444,000USD-7,853,000USD-9,902,000USD-12,419,000USD-1,957,000USD
    Unclassified Non Current Liabilities—78,221,999USD69,742,000USD68,364,000USD67,949,000USD61,457,000USD56,798,000USD57,707,000USD
    Unclassified Equity—138,174,999USD137,764,000USD137,330,000USD136,991,000USD136,812,000USD136,633,000USD136,453,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Assets1,501,241,000USD1,360,900,000USD982,184,000USD971,397,000USD931,699,000USD841,325,000USD784,100,000USD726,671,000USD
    Cash And Equivalents61,419,000USD———————
    Cash And Short Term Investments81,994,000USD77,039,000USD114,613,000USD81,281,000USD91,248,000USD93,212,000USD91,343,000USD81,573,000USD
    Short Term Investments20,575,000USD9,000,000USD44,000,000USD40,000,000USD17,000,000USD43,000,000USD55,000,000USD24,000,000USD
    Long Term Investments8,759,000USD11,689,000USD11,488,000USD11,094,000USD10,346,000USD10,105,000USD10,020,000USD9,627,000USD
    Total Current Assets935,506,000USD810,606,000USD600,997,000USD585,723,000USD566,232,000USD498,909,000USD451,837,000USD466,162,000USD
    Other Current Assets79,835,000USD61,159,000USD51,021,000USD63,393,000USD49,289,000USD42,533,000USD37,313,000USD27,245,000USD
    Other Non Current Assets106,464,000USD———————
    Total Liabilities1,115,764,000USD———————
    Total Current Liabilities316,468,000USD293,473,000USD204,148,000USD176,000,000USD190,832,000USD164,116,000USD157,238,000USD154,227,000USD
    Other Current Liabilities29,933,000USD———————
    Other Non Current Liabilities91,527,000USD———————
    Total Stockholder Equity385,477,000USD285,682,000USD256,641,000USD282,509,000USD262,442,000USD238,529,000USD188,204,000USD216,015,000USD
    Total Equity Including Noncontrolling Interest385,477,000USD———————
    Net Receivables238,794,000USD227,983,000USD169,452,000USD163,479,000USD166,537,000USD146,852,000USD126,522,000USD159,022,000USD
    Inventory534,883,000USD444,425,000USD265,911,000USD277,570,000USD259,158,000USD216,312,000USD196,659,000USD198,322,000USD
    Property Plant Equipment Net420,748,000USD396,029,000USD240,904,000USD231,327,000USD203,170,000USD187,668,000USD170,982,000USD140,235,000USD
    Goodwill60,045,000USD———————
    Accounts Payable127,314,000USD138,201,000USD85,567,000USD73,853,000USD95,596,000USD68,362,000USD66,091,000USD73,189,000USD
    Short Term Debt10,572,000USD25,377,000USD37,255,000USD28,348,000USD21,051,000USD15,993,000USD25,189,000USD12,540,000USD
    Retained Earnings352,958,000USD272,701,000USD243,886,000USD260,912,000USD247,748,000USD218,015,000USD183,060,000USD168,926,000USD
    Accumulated Other Comprehensive Income-106,077,000USD-124,018,000USD-123,527,000USD-114,210,000USD-121,113,000USD-115,293,000USD-130,385,000USD-86,181,000USD
    Intangible Assets—36,469,000USD45,033,000USD54,987,000USD63,861,000USD62,282,000USD70,997,000USD47,478,000USD
    Total Liab—1,075,218,000USD725,543,000USD688,888,000USD669,257,000USD602,796,000USD595,896,000USD510,656,000USD
    Other Current Liab—121,498,000USD78,395,000USD65,136,000USD66,974,000USD73,654,000USD62,137,000USD62,431,000USD
    Common Stock—4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Capital Stock—4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Good Will—59,645,000USD54,557,000USD53,274,000USD53,226,000USD52,679,000USD52,679,000USD27,348,000USD
    Cash—68,039,000USD70,613,000USD41,281,000USD74,248,000USD50,212,000USD36,343,000USD57,573,000USD
    Net Debt—693,513,000USD454,846,000USD468,685,000USD396,236,000USD376,494,000USD374,379,000USD268,602,000USD
    Short Long Term Debt—16,250,000USD29,795,000USD22,295,000USD15,000,000USD9,375,000USD18,750,000USD12,540,000USD
    Short Long Term Debt Total—761,552,000USD525,459,000USD509,966,000USD470,484,000USD426,706,000USD410,722,000USD326,175,000USD
    Long Term Debt—702,435,000USD458,289,000USD452,541,000USD417,925,000USD382,710,000USD368,257,000USD96,000,000USD
    Property Plant Equipment Gross—674,989,000USD486,258,000USD494,953,000USD444,135,000USD187,668,000USD170,982,000USD140,235,000USD
    Common Stock Shares Outstanding—40,700,000shares40,523,000shares40,504,000shares40,500,000shares40,500,000shares40,500,000shares40,523,000shares
    Non Current Assets Total—550,294,000USD381,187,000USD385,674,000USD365,467,000USD342,416,000USD332,263,000USD260,509,000USD
    Non Current Liabilities Total—781,745,000USD521,395,000USD512,888,000USD478,425,000USD438,680,000USD438,658,000USD356,429,000USD
    Non Current Liabilities Other—11,361,000USD6,846,000USD60,347,000USD60,500,000USD7,594,000USD16,625,000USD42,794,000USD
    Non Currrent Assets Other—20,914,000USD9,834,000USD26,281,000USD29,015,000USD19,821,000USD16,155,000USD19,051,000USD
    Net Working Capital—517,133,000USD396,849,000USD409,723,000USD375,400,000USD334,793,000USD294,599,000USD311,935,000USD
    Unclassified Non Current Assets—25,548,000USD19,371,000USD-22,123,000USD-22,127,000USD-25,785,000USD-21,956,000USD-24,482,000USD
    Unclassified Current Liabilities—-7,853,000USD-29,795,000USD-14,002,000USD-8,611,000USD-62,193,000USD-59,709,000USD-59,316,000USD
    Unclassified Non Current Liabilities—67,949,000USD56,260,000USD-32,678,000USD-30,428,000USD18,598,000USD6,024,000USD173,310,000USD
    Unclassified Equity—136,991,000USD136,274,000USD135,799,000USD135,799,000USD135,799,000USD135,521,000USD133,262,000USD
    Current Deferred Revenue——2,931,000USD370,000USD822,000USD58,925,000USD44,780,000USD52,843,000USD
    Deferred Long Term Liab———1,408,000USD1,436,000USD1,811,000USD1,021,000USD1,531,000USD
    Other Liab———31,270,000USD28,992,000USD27,967,000USD46,731,000USD42,794,000USD
    Other Assets———30,834,000USD27,976,000USD35,646,000USD33,386,000USD41,252,000USD
    Net Tangible Assets———174,248,000USD145,355,000USD123,568,000USD64,528,000USD141,189,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Depreciation51,514,000USD45,605,000USD36,178,000USD34,012,000USD32,705,000USD31,885,000USD32,341,000USD27,564,000USD
    Stock Based Compensation1,597,000USD717,000USD475,000USD-10,398,000USD0USD1,129,000USD2,259,000USD2,259,000USD
    Deferred Income Tax7,226,000USD———————
    Other Non Cash Items1,913,000USD11,979,000USD23,251,000USD1,061,000USD-4,786,000USD-7,041,000USD-3,273,000USD-1,319,000USD
    Change To Account Receivables-7,493,000USD-55,208,000USD-8,678,000USD5,335,000USD-23,625,000USD-18,209,000USD28,713,000USD-23,679,000USD
    Change To Inventory-86,338,000USD-44,294,000USD2,641,000USD-11,222,000USD-46,999,000USD-12,498,000USD-12,930,000USD-20,982,000USD
    Change To Liabilities13,888,000USD——-28,577,000USD29,510,000USD3,176,000USD-16,181,000USD16,190,000USD
    Change In Working Capital-121,447,000USD-21,562,000USD33,114,000USD-41,133,000USD-44,639,000USD-29,869,000USD-13,656,000USD-35,943,000USD
    Operating Cash Flow68,954,000USD———————
    Capital Expenditures-59,088,000USD-38,293,000USD-41,238,000USD-51,794,000USD-37,044,000USD-29,320,000USD-34,045,000USD-29,891,000USD
    Other Investing Activities792,000USD———————
    Unclassified Investing Cash Flow-13,159,000USD37,159,000USD40,912,000USD————-9,838,000USD
    Investing Cash Flow-71,455,000USD———————
    Common Dividends Paid-19,463,000USD———————
    Unclassified Financing Cash Flow12,903,000USD——-324,527,000USD-306,375,000USD-617,500,000USD-243,000,000USD-216,775,000USD
    Financing Cash Flow-6,560,000USD———————
    Effect Of Forex Changes On Cash2,441,000USD———————
    Change In Cash-6,620,000USD-2,574,000USD29,332,000USD-32,967,000USD24,036,000USD13,869,000USD-21,230,000USD28,405,000USD
    End Cash Flow61,419,000USD———————
    Net Income—48,264,000USD2,416,000USD32,606,000USD49,175,000USD54,385,000USD33,552,000USD54,713,000USD
    Total Cash From Operating Activities—80,124,000USD87,594,000USD13,310,000USD31,649,000USD48,306,000USD59,348,000USD47,169,000USD
    Free Cash Flow—41,831,000USD46,356,000USD-38,484,000USD-5,395,000USD18,986,000USD25,303,000USD17,278,000USD
    Investments—-288,688,000USD-48,194,000USD-23,000,000USD27,353,000USD12,000,000USD-31,000,000USD26,000,000USD
    Total Cashflows From Investing Activities—-288,688,000USD-48,194,000USD-74,018,000USD-22,582,000USD-18,580,000USD-120,390,000USD-14,133,000USD
    Net Borrowings—235,986,000USD12,705,000USD41,212,000USD50,000,000USD5,375,000USD60,354,000USD13,351,000USD
    Total Cash From Financing Activities—207,134,000USD-6,768,000USD26,987,000USD16,343,000USD-16,995,000USD40,936,000USD-4,107,000USD
    Dividends Paid—-19,449,000USD-19,442,000USD-19,442,000USD-19,442,000USD-19,430,000USD-19,418,000USD-18,592,000USD
    Begin Period Cash Flow—70,613,000USD41,281,000USD74,248,000USD50,212,000USD36,343,000USD57,573,000USD29,168,000USD
    End Period Cash Flow—68,039,000USD70,613,000USD41,281,000USD74,248,000USD50,212,000USD36,343,000USD57,573,000USD
    Other Cashflows From Investing Activities—1,134,000USD326,000USD776,000USD-12,891,000USD-1,260,000USD-55,345,000USD-404,000USD
    Other Cashflows From Financing Activities—-9,403,000USD-31,000USD329,744,000USD292,160,000USD614,560,000USD243,000,000USD216,775,000USD
    Unclassified Operating Cash Flow—-4,879,000USD-7,840,000USD-2,838,000USD—-2,183,000USD8,125,000USD—
    Cash And Cash Equivalents Changes———-33,721,000USD25,410,000USD13,869,000USD-21,230,000USD28,405,000USD
    Issuance Of Capital Stock—————0USD0USD1,134,000USD
    Exchange Rate Changes—————1,138,000USD-1,124,000USD-524,000USD
    Sale Purchase Of Stock———————1,134,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
    Net Income24,024,000USD27,459,000USD26,527,000USD17,224,000USD20,880,000USD3,185,000USD6,975,000USD752,000USD
    Depreciation12,448,000USD12,891,000USD12,830,000USD12,411,000USD12,616,000USD11,574,000USD9,004,000USD9,201,000USD
    Stock Based Compensation411,000USD434,000USD339,000USD179,000USD179,000USD180,000USD179,000USD179,000USD
    Other Non Cash Items2,784,000USD-185,000USD976,000USD-2,650,000USD1,669,000USD13,571,000USD-611,000USD2,638,000USD
    Change To Account Receivables-4,776,000USD2,333,000USD11,366,000USD-25,957,000USD-3,470,000USD-34,989,000USD9,208,000USD-11,723,000USD
    Change To Inventory-19,328,000USD-47,032,000USD-26,181,000USD-6,161,000USD-13,732,000USD-19,237,000USD-5,164,000USD8,532,000USD
    Change In Working Capital-26,709,000USD-25,085,000USD-33,541,000USD-14,254,000USD8,428,000USD-17,694,000USD1,958,000USD20,895,000USD
    Total Cash From Operating Activities16,206,000USD19,352,000USD9,302,000USD21,272,000USD43,154,000USD3,076,000USD12,622,000USD28,429,000USD
    Capital Expenditures-15,316,000USD-11,097,000USD-13,806,000USD-13,142,000USD-7,746,000USD-7,822,000USD-9,583,000USD-13,072,000USD
    Free Cash Flow890,000USD8,255,000USD-4,504,000USD8,130,000USD35,408,000USD-4,746,000USD3,039,000USD15,357,000USD
    Investments-3,500,000USD-6,518,000USD-21,014,000USD-7,034,000USD-18,251,000USD-260,473,000USD-2,930,000USD-9,111,000USD
    Total Cashflows From Investing Activities-16,806,000USD-17,184,000USD-21,014,000USD-7,034,000USD-18,251,000USD-260,473,000USD-2,930,000USD-9,111,000USD
    Net Borrowings3,937,000USD-12,062,000USD23,937,000USD-9,061,000USD-26,063,000USD283,125,000USD-12,015,000USD—
    Total Cash From Financing Activities-2,300,000USD-18,980,000USD16,335,000USD-7,766,000USD-32,223,000USD276,320,000USD-29,197,000USD1,787,000USD
    Dividends Paid-4,868,000USD-4,864,000USD-4,864,000USD-4,864,000USD-4,865,000USD-4,860,000USD-4,860,000USD-4,861,000USD
    Change In Cash-557,000USD-17,283,000USD4,730,000USD7,685,000USD-6,720,000USD15,237,000USD-18,776,000USD20,388,000USD
    Begin Period Cash Flow55,486,000USD72,769,000USD68,039,000USD60,354,000USD67,074,000USD51,837,000USD70,613,000USD50,225,000USD
    End Period Cash Flow54,929,000USD55,486,000USD72,769,000USD68,039,000USD60,354,000USD67,074,000USD51,837,000USD70,613,000USD
    Other Cashflows From Investing Activities2,010,000USD431,000USD-3,704,000USD-241,000USD548,000USD174,000USD653,000USD-562,000USD
    Other Cashflows From Financing Activities-1,369,000USD-2,054,000USD-2,738,000USD242,145,000USD-1,295,000USD-1,945,000USD-12,322,000USD2,628,000USD
    Unclassified Operating Cash Flow3,248,000USD3,838,000USD2,171,000USD8,362,000USD—-7,740,000USD-4,883,000USD-5,236,000USD
    Unclassified Investing Cash Flow——17,510,000USD13,383,000USD7,198,000USD7,648,000USD8,930,000USD13,634,000USD
    Unclassified Financing Cash Flow———-235,986,000USD———4,020,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2026Quarterly · 2026-03-31GeographyAsia Pacific30,685,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31GeographyEMEA44,468,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31GeographyLatin America And Canada75,619,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31GeographyUnited States232,771,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31ProductAnimal Health — Medicated Feed Additives And Others205,789,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31ProductAnimal Health — Nutritional Specialties46,810,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31ProductAnimal Health — Vaccines38,626,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31ProductMineral Nutrition73,418,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31ProductPerformance Products18,900,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31SegmentAnimal Health291,225,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31SegmentMineral Nutrition73,418,000USD0001104659-26-056280
    Q3 2026Quarterly · 2026-03-31SegmentPerformance Products18,900,000USD0001104659-26-056280
    Q2 2026Quarterly · 2025-12-31GeographyAsia Pacific19,769,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31GeographyEMEA44,784,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31GeographyLatin America And Canada87,600,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31GeographyUnited States221,757,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31ProductAnimal Health — Medicated Feed Additives And Others202,111,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31ProductAnimal Health — Nutritional Specialties50,230,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31ProductAnimal Health — Vaccines37,636,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31ProductMineral Nutrition68,945,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31ProductPerformance Products14,988,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31SegmentAnimal Health289,977,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31SegmentMineral Nutrition68,945,000USD0001104659-26-010317
    Q2 2026Quarterly · 2025-12-31SegmentPerformance Products14,988,000USD0001104659-26-010317
    Q1 2026Quarterly · 2025-09-30GeographyAsia Pacific29,378,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30GeographyEMEA44,942,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30GeographyLatin America And Canada87,226,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30GeographyUnited States202,347,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30ProductAnimal Health — Medicated Feed Additives And Others195,198,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30ProductAnimal Health — Nutritional Specialties48,151,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30ProductAnimal Health — Vaccines40,107,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30ProductMineral Nutrition62,988,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30ProductPerformance Products17,449,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30SegmentAnimal Health283,456,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30SegmentMineral Nutrition62,988,000USD0001104659-25-107001
    Q1 2026Quarterly · 2025-09-30SegmentPerformance Products17,449,000USD0001104659-25-107001
    Q4 2025Quarterly · 2025-06-30GeographyAsia Pacific35,029,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30GeographyEMEA57,608,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30GeographyLatin America And Canada84,071,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30GeographyUnited States201,989,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30ProductAnimal Health — Medicated Feed Additives And Others206,527,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30ProductAnimal Health — Nutritional Specialties47,381,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30ProductAnimal Health — Vaccines38,570,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30ProductMineral Nutrition64,154,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30ProductPerformance Products22,065,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentAnimal Health292,478,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentMineral Nutrition64,154,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentPerformance Products22,065,000USDLegacy provider
    FY 2025Yearly · 2025-06-30GeographyAsia Pacific97,415,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30GeographyEMEA160,232,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30GeographyLatin America And Canada298,649,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30GeographyUnited States739,919,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30ProductAnimal Health — Medicated Feed Additives And Others646,354,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30ProductAnimal Health — Nutritional Specialties179,289,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30ProductAnimal Health — Vaccines137,153,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30ProductMineral Nutrition253,240,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30ProductPerformance Products80,179,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30SegmentAnimal Health962,796,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30SegmentMineral Nutrition253,240,000USD0001558370-25-011776
    FY 2025Yearly · 2025-06-30SegmentPerformance Products80,179,000USD0001558370-25-011776
    Q3 2025Quarterly · 2025-03-31GeographyAsia Pacific28,222,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31GeographyEMEA38,910,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31GeographyLatin America And Canada70,753,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31GeographyUnited States209,940,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31ProductAnimal Health — Medicated Feed Additives And Others181,645,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31ProductAnimal Health — Nutritional Specialties43,350,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31ProductAnimal Health — Vaccines33,382,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31ProductMineral Nutrition66,774,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31ProductPerformance Products22,674,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31SegmentAnimal Health258,377,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31SegmentMineral Nutrition66,774,000USD0001104659-26-056280
    Q3 2025Quarterly · 2025-03-31SegmentPerformance Products22,674,000USD0001104659-26-056280
    Q2 2025Quarterly · 2024-12-31GeographyAsia Pacific19,557,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31GeographyEMEA32,589,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31GeographyLatin America And Canada72,674,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31GeographyUnited States184,441,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31ProductAnimal Health — Medicated Feed Additives And Others150,338,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31ProductAnimal Health — Nutritional Specialties45,909,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31ProductAnimal Health — Vaccines33,171,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31ProductMineral Nutrition63,250,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31ProductPerformance Products16,593,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31SegmentAnimal Health229,418,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31SegmentMineral Nutrition63,250,000USD0001104659-26-010317
    Q2 2025Quarterly · 2024-12-31SegmentPerformance Products16,593,000USD0001104659-26-010317
    Q1 2025Quarterly · 2024-09-30GeographyAsia Pacific14,607,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30GeographyEMEA31,125,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30GeographyLatin America And Canada71,151,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30GeographyUnited States143,549,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30ProductAnimal Health — Medicated Feed Additives And Others107,844,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30ProductAnimal Health — Nutritional Specialties42,649,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30ProductAnimal Health — Vaccines32,030,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30ProductMineral Nutrition59,062,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30ProductPerformance Products18,847,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30SegmentAnimal Health182,523,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30SegmentMineral Nutrition59,062,000USD0001104659-25-107001
    Q1 2025Quarterly · 2024-09-30SegmentPerformance Products18,847,000USD0001104659-25-107001
    Q4 2024Quarterly · 2024-06-30GeographyAsia Pacific16,913,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30GeographyEMEA32,405,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30GeographyLatin America And Canada70,166,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30GeographyUnited States153,680,000USDLegacy provider

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.